The azgA gene of Aspergillus nidulans encodes a hypoxanthine-adenine-guanine transporter. It has been cloned by a novel transposon methodology. The null phenotype of azgA was defined by a number of mutations, including a large deletion. In mycelia, the azgA gene is, like other genes of purine catabolism, induced by uric acid and repressed by ammonium. Its transcription depends on the pathway-specific UaY Zn binuclear cluster protein and the broad domain AreA GATA factor. AzgA is not closely related to any other characterised membrane protein, but many close homologues of unknown function are present in fungi, plants and prokaryotes but not metazoa. Two out of three data bases and the phylogeny presented in this article places proteins of this family in a cluster clearly separated (but perhaps phylogenetically related) from the NAT family which includes other eukaryotic and prokaryotic nucleobase transporters. Thus AzgA is the first characterised member of this family or sub-family of membrane proteins.
Introduction
Three purine transporters exist in Aspergillus nidulans (1) (2) (3) . UapA is specific for uric acid and xanthine. UapC is able to transport all purines albeit with different K m s and capacities. UapC is a xanthine-uric acid transporter with a low capacity activity for hypoxanthine and other purines. These two proteins are homologues and belong to the Nucleobase-Ascorbate Transporter (NAT) family, conserved in fungi, prokaryotes, plants and mammals (2, 3) . Members of this family transport purines, pyrimidines and surprisingly in mammals, ascorbic acid (4) . The determinants of the substrate specificity of this family of proteins have been studied in detail (5, 6 ). This family is referred also as the Nucleobase/Cation symporter 2 (NCS2) family (Accession TIGR00801, 7). The mammalian ascorbate transporter is a Na + symporter (8) . Four proteins of this family, the fungal transporter UapA, the plant transporter . The resulting product was subjected to a second PCR using nested oligonucleotides . The resulting product was cloned in pGEM  -T easy vector (Promega Biosciences, San Luis Obispo, USA).
5' and 3' RACE analysis.
The start and the end of transcription of the azgA gene was determined using the 5'/3'-RACE kit (Roche Diagnostics, Indianapolis, USA). In 5'-RACE experiment, the cDNA was obtained using the specific oligonucleotides . In the 3'-RACE experiment, the initial cDNA was obtained using the specific oligonucleotide 5' TCTCCGCCTGTTACAGCATT 3' . Two CCGGTATCTGCTTCTTCAT 3' respectively to increase specificity. The resulting product was cloned in the pGEM  -T easy vector (Promega Biosciences, San Luis Obispo, USA).
Sequence determination.
Sequences were determined using the "Big Dye terminator cycle sequencing ready reaction with AmpliTaq DNA polymerase" kit on an ABI310 sequencing apparatus (Perkin-Elmer, Warrington). The azgA gene was sequenced on both strands using two independent clones. When necessary a third clone was sequenced.
Transformation techniques.
Transformation of E. coli was performed by electroporation with a MicroPulser  (BIO-RAD, Hercules). Transformation of A. nidulans was according to (27).
Purine Transport Assays. normally expressed and thus this strain is unable to grow on nitrate as nitrogen source but has green conidiospores. On excision of impala the niaD leader will be restored and the strain will recover the ability to utilise nitrate. The characteristics of the strain and the strategy used are shown in figure 2 . We selected 248 8-azaguanine resistant mutants in the CS2757 strain. Of these, only one had become niaD + . This phenotype shows that the transposon has been excised from the niaD promoter, but not that it has inserted concomitantly in the azgA gene. This was shown as follows.
The resulting strain CS3107 was crossed with a yA -strain (CS2748), and the progeny checked for conidiospore colour, 8-azaguanine resistance and ability to utilise hypoxanthine as nitrogen source. In 300 progeny analysed, all strains resistant to 8-azaguanine and defective in hypoxanthine utilisation (azgA -) were yA
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This fragment was sequenced and shown to contain a sequence highly similar to the amino-terminus of a Schizosaccharomyces pombe membrane protein of unknown function. We could thus assume that we have cloned the 5' of the azgA gene. The missing 3' sequences were obtained as a cDNA by a 3' RACE experiment using RNA from the wild type strain and primers able to hybridise with the previously determined sequence. This cDNA included the 3' terminus of the RNA. Then, the corresponding genomic DNA was amplified by PCR and its sequence determined.
We then sequenced a 3013 bp fragment containing a 2012 pb ORF interrupted by 4 putative introns. The start-point of transcription and the exact location of introns 1 and 2 were determined by 5' RACE experiment using RNA from the wild type strain grown on adenine containing medium (see Materials and methods). We amplified by RT-PCR an internal cDNA fragment overlapping both the 5' and 3' RACE fragments. Sequencing this fragment allowed us to map the boundaries of introns 3 and 4. The exact position of the 5' and 3' mRNA termini and of the introns is shown in figure 3 . The insertion of impala had occurred at the TA sequence at the 5' splice site of intron 1 as shown by the IPCR sequence (see above).
A 2.6 Kb fragment overlapping the insertion point was amplified and used as a probe in Southern blots against DNA extracted from wild type, azgA4 and azgA108 strains. The wild type and the azgA4 strains have identical restriction patterns, while the azgA108 strain pattern shows the presence of the transposon (data not shown).
Thus that the cloned fragment corresponds to the primary transposition event in the CS3107 mutated strain. The azgA sequence data have been submitted to the EMBL database under accession number AJ575188.
The whole 3013 bp fragment was amplified from total genomic DNA of the wild type strain and cloned in the pGEM  -T easy vector. The resulting plasmid is able to complement an azgA4 mutation in transformation experiments (results not shown). intron consensus splicing sequence.
AzgA defines a new family or subfamily of membrane proteins.
No AzgA homologues of known function were identified. Many homologues of unknown function were found in data bases of fungi, plants, bacteria and archea.
AzgA is different from every previously described family of purine or pyrimidine transporters. The most similar proteins are found in Neurospora crassa and figure 4D ) overlaps a region that is essential for substrate recognition in UapA and UapC (5, 6) . Within this region, a typical motif we have described as a signature of the NAT family (FYS)x(QEP)NxGφφxφT(KRG), where φ is a hydrophobic amino acid, (4,5) is not present in AzgA and its homologues. The N residue included in the motif is one of the two polar residues that are conserved among all members of the NAT family. In UapA, the N residue and the preceding Q (also absent in AzgA), are determinants of substrate specificity and transport kinetics 6 (6,31). The second region includes another motif (defined in PROSITE as different from that of members of the NAT family (12 to 14 transmembrane segments according to the programme). Figure 5 shows the phylogenetic relationships between the proteins of the azgA family and those of the NAT family.
Molecular characterisation of azgA mutants.
We amplified PCR fragments corresponding to the entire azgA sequence from mutants azgA4, azgA201, azgA212 and azgA217. These were sequenced. The azgA201 allele corresponds to a deletion of 1. Thus azgA, as all other purine catabolic genes, is under the control of both UaY and AreA. However, these results could be explained either at the level of direct interaction of these transcription factors with the azgA promoter or at the level of inducer exclusion. This point will be dealt below.
Discussion
Uptake studies have established that AzgA is a high-affinity, high-capacity hypoxanthine transporter. Competition studies strongly suggest that AzgA also transports with high-capacity and high-affinity adenine. Hypoxanthine transport by
AzgA is competed by, and thus AzgA probably transports, albeit with reduced capacity and affinity, guanine, guanosine, 6-thioguanine and 8-azaxanthine.
Competition by 8-azaxanthine was unexpected as xanthine is not a substrate of AzgA. It is also surprising that 8-azaguanine, which is very toxic for strains with a wild type azgA gene does not compete hypoxanthine uptake. The K m values of AzgA for its major substrates, hypoxanthine and adenine, ranges between 1.4-3.0 µM, which are lower than those of UapA (7-10 µM) and UapC (8-24 µM) for their cognate substrates (5). This makes teleonomic sense. The substrates of the AzgA transporter can serve both as sources of purines through the salvage pathway and as nitrogen sources, while xanthine and uric acid can serve only as nitrogen sources.
AzgA is the first physiologically characterised member of a related family or subfamily of transporters. AzgA and its homologues have no obvious extended similarities with any nucleobase transporter characterised previously. This includes transporters of the PRT family (4) as the S. cerevisiae FCY2 adenine-hypoxanthinecytosine transporter (49) and its homologues in C. albicans, the plant PUP family like the AtPUP1 adenine hypoxanthine cytosine transporter of A. thaliana (50), the mamamalian ENT2 nucleoside facilitated diffusion protein, which is also able to transporte nucleobases (51) and the Trypanosome transporter TbNT5 (52).
We have indicated some differences and similarities with members of the NAT family. These suggest that the two families may be related. It is an arbitrary decision whether to place the two groups in separate families of proteins or in one family with two highly divergent sub-families. The non-conservation of residues involved in substrate recognition comforts the divisive rather than the gathering taxonomy.
In fact, the methodology used to construct the tree shown in figure 5 (sequences alignement using ClustalW) maximises identities and thus possible phylogentic relationships. The COG database phylogenetic trees define the azgA-like proteins as a separate family, while the TransportDB data base includes them in the NAT family but in a clearly separate cluster.
The transcriptional regulation of this transporter in growing mycelium is identical to that of well characterised genes of purine catabolism (reviewed in 41). The transcription of AzgA is inducible by uric acid, repressible by ammonium and dependent on the GATA factor AreA and the pathway specific factor UaY. This seems to contradict the fact that 8-azaguanine is toxic on agar plates in the presence of ammonium, in the absence of effectors of UaY (uric acid and its thio-analogues, Preliminary in vivo methylation protection experiments strongly suggest that UaY binds to at least the UaY promoter proximal site only in the presence of inducer 7 .
In an AreA null mutant neither uric acid can be taken up nor can hypoxanthine be converted to uric acid. Thus the impairment of expression of azgA in an areA600 mutation could be due to inducer exclusion, to a direct involvement of AreA in azgA transcription or to both mechanisms. Area binds to sequences responding to the Putative or characterised transporters from the NAT family were identified using blastX and the UapA sequence from A. nidulans (Accession Q07307) as a probe: Uric Acid 113 ± 8 T  T  T  T  T  T  T  T  T L  V  I  I  L  V  I  V   V  T  T  T  T  T  T  C  T  T   L  I  A  V  I  V  I  I  I  I   I  I  L  I 
